The Pharos Vitesse is Micrus Endovascular’s balloon-expandable stent for intracranial ischemic stenosis and wide-neck aneurysm treatment.
Micrus intends to immediately begin selling the Pharos Vitesse stent in the approved geographies through its direct sales and distribution network.
The Pharos Vitesse is manufactured exclusively for Micrus Endovascular through a collaborative agreement with Switzerland-based Biotronik.
John Kilcoyne, chairman and CEO of Micrus Endovascular, said: “CE Mark authorization of the Pharos Vitesse stent supports our expansion into the large ischemic stroke market with a product that has important value-added features.”